MediThinQ and Synovis MCA Sign Global Distribution Agreement for SHIYA Surgical Visualisation Platform
19 June 2026
MediThinQ, a South Korea-based developer of surgical visualisation technologies, has signed an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. (Synovis MCA), a subsidiary of Baxter International, to commercialise its SHIYA 3D surgical visualisation platform. Financial details of the agreement were not disclosed.
The partnership will support the global rollout of SHIYA through Synovis MCA’s established microsurgery network and relationships with hospitals and reconstructive surgeons. With more than 30 years of experience in microsurgery, Synovis MCA will help accelerate the adoption of the platform across international markets.
SHIYA was developed to overcome limitations associated with conventional surgical microscopes, which require surgeons to work through fixed eyepieces. The fully digital platform combines a high-resolution digital exoscope offering up to 20x magnification with MediThinQ’s wearable display technology, SCOPEYE.
The system enables surgeons to operate without traditional eyepieces while supporting real-time capture, storage and sharing of surgical data. This digital approach is expected to support the development of data-driven surgery, including future applications involving artificial intelligence, advanced analytics and robotic-assisted procedures.
The platform also aims to improve surgical ergonomics through a heads-up operating position and provides greater visibility for the wider surgical team. Its portable design may help increase access to advanced visualisation technologies, particularly in healthcare settings where conventional microscopes are costly or difficult to deploy.
According to MediThinQ, SHIYA has been used in more than 100 surgical procedures worldwide and has been evaluated through peer-reviewed studies. Research published in JPRAS Open in 2025 highlighted the potential of digital exoscope systems in microsurgery and their suitability for emerging technologies such as augmented and data-assisted surgery.
In addition, a study published in Plastic and Reconstructive Surgery examined the portability and ergonomic benefits of 3D exoscopes with heads-up displays. The findings suggested that such systems could serve as an alternative to traditional microscopes and support applications in supermicrosurgery, telemicrosurgery and robotic-assisted surgery.
Medical experts involved in the studies noted that digital visualisation systems can improve collaboration, training opportunities and surgeon comfort by allowing the entire surgical team to share the same view of the operating field.
The agreement will allow MediThinQ to use Synovis MCA’s commercial and clinical capabilities to expand SHIYA’s presence globally. The rollout will be introduced in phases, with implementation tailored to regulatory requirements and market conditions in individual countries.
MediThinQ said the partnership supports its goal of making digital surgical visualisation more accessible and helping surgeons benefit from improved visibility, ergonomics and workflow efficiency.
Synovis MCA stated that the collaboration aligns with its focus on providing innovative microsurgical solutions and will support the future development of digital microsurgery technologies.
MediThinQ is also advancing its broader “3D Surgical Intelligence” initiative, which aims to combine visualisation, data collection and analytics within a connected surgical environment.
Source: prnewswire.com